The effects of angiotensin II receptor blockade on renal blood flow in atherosclerotic kidney disease

The effects of angiotensin II receptor blockade on renal blood flow in atherosclerotic kidney disease - The effects of angiotensin II receptor blockade on renal blood flow

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000021355

Enrollment

40

Registered

2016-03-31

Start date

2011-03-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic kidney disease

Interventions

100mg of irbesartan

Sponsors

Keio University, School of Medicine

Lead Sponsor

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: hypertensive patients with CKD

Exclusion criteria

Exclusion criteria: patients with diabets

Design outcomes

Primary

Measure	Time frame
The change in pulse doppler parameters one year after the treatment with ARB	—

Countries

Japan

Contacts

Public ContactShu Wakino

Keio University, School of Medicine Division of Nephrology, Endocrinology, and Diabetes

shuwakino@z8.keio.jp03-3353-1211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026